Rankings
▼
Calendar
IOVA Q2 2016 Earnings — Iovance Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena
IOVA
Iovance Biotherapeutics, Inc.
$2B
Q2 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$12M
Net Income
-$12M
EPS (Diluted)
$-0.23
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$194M
Total Liabilities
$5M
Stockholders' Equity
$189M
Cash & Equivalents
$101M
← FY 2016
All Quarters
Q3 2016 →
